Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies

The unmet clinical need for effective treatments in ovarian cancer has yet to be addressed using monoclonal antibodies (mAbs), which have largely failed to overcome tumour-associated immunosuppression, restrict cancer growth, and significantly improve survival. In recent years, experimental mAb desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Osborn, Gabriel, Stavraka, Chara, Adams, Rebecca, Sayasneh, Ahmad, Ghosh, Sharmistha, Montes, Ana, Lacy, Katie E, Kristeleit, Rebecca, Spicer, James, Josephs, Debra H, Arnold, James N, Karagiannis, Sophia N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review Series: Immune cell-antibody interactions in health and disease (Series Editors: Sophia Karagiannis and James Arnold)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307234/
https://www.ncbi.nlm.nih.gov/pubmed/35020853
http://dx.doi.org/10.1093/cei/uxab020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307234/
https://www.ncbi.nlm.nih.gov/pubmed/35020853
http://dx.doi.org/10.1093/cei/uxab020

Ejemplares similares